Senior insider sale
Sr VP, Quality, GMP Oper. & IT at SUPERNUS PHARMACEUTICALS, INC. — senior position signals high conviction
$87.1K
1.62K shares
What this filing means
MOTTOLA FRANK plans to sell 1.62K shares of SUPERNUS PHARMACEUTICALS, INC. valued at approximately $87.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/9/2026ACC: 0001950047-26-002357
Officer· Sr VP, Quality, GMP Oper. & IT
Since Feb 2020
1.62K
Shares to sell
$87.1K
Approx. market value
1.62K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted stock vesting under a registered plan
Not Applicable
2/22/2024
415.00Restricted stock vesting under a registered plan
Not Applicable
2/22/2023
461.00Restricted stock vesting under a registered plan
Not Applicable
1/12/2023
747.00Total acquired1.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/22/2024 | Restricted stock vesting under a registered plan Not Applicable | 415.00 | — |
2/22/2023 | Restricted stock vesting under a registered plan Not Applicable | 461.00 | — |
1/12/2023 | Restricted stock vesting under a registered plan Not Applicable | 747.00 | — |
| Total | 1.62K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.62K
Market value
$87.1K
3/9/2026
Total
Units
1.62K
Value
$87.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/9/2026 | 1.62K | $87.1K | NASDAQ | Planned |
| Total | 1.62K | $87.1K | ||